Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial. - Branch KRH; Dagenais GR; Avezum A; Basile J; Conget I; Cushman WC; Jansky P; Lakshmanan M; Lanas F; Leiter LA; Pais P; Pogosova N; et al. (European journal of heart failure, 2022)